Regine Eibl-Schindler is a Professor at the Zurich University of Applied Sciences (ZHAW) , School of Life Sciences and Facility Management. She leads the Center for Cell Cultivation Techniques, Tissue Engineering and Medical Biology, focusing on advanced bioreactor design and biopharmaceutical production processes. Project leader in bioreactor optimization for therapeutic cell production Deputy leader in vaccine and antibody manufacturing innovations Co-developer of single-use systems for stem cell and microbial cultures Her research spans bioreactor engineering , computational fluid dynamics (CFD) modeling , and process intensification for scalable cell culture systems. She has pioneered microcarrier-based cultivation of induced pluripotent stem cells and mesenchymal stem cells , emphasizing xeno-free media and disposable technologies. Recent work includes automated bioreactor qualification and shear stress optimization for cell growth. Her expertise in single-use bioreactors has been applied to diverse fields including cell therapy manufacturing , vaccine development , and cellular agriculture for clean meat production. She developed standardized qualification protocols for novel bioreactor designs and advanced process analytical technology (PAT) for real-time cell health monitoring. Key collaborations include optimizing CHO cell antibody production , HEK293 cell expansion , and plant cell bioreactors for pharmaceutical and food applications. Her work bridges bioprocess engineering with regenerative medicine , ensuring compliance with regulatory standards through rigorous CFD simulations and scale-up methodologies .







